Apple stops deal (in) its well- connected watches due to a patent dispute

APPLE said Monday it will stop selling its Series 9 and Ultra 2 smartwatches in the U.S. starting this week amid a patent dispute over technology that supplies oxygen to blood collection devices.

The decision follows an October order from the US International Trade Commission (ITC) that could ban Apple from importing Apple Watches after finding the devices violated the company’s patent rights. Medical technology out of Masimo.

The decision will be reappraisal by President Joe Biden by December 25, but Apple said it would take steps to comply with the award UNITED STATES . The Office of the Trade archetypal which is part of the Biden administration and is handling the matter, said Ambassador Katherine Tai was “carefully reviewing all factors related to this matter.” Unless vetoed, the ban will take effect on December 26th.

The company announced that it would stop selling watches on its website on December 21 and in Apple Stores on December 24. The controversy doesn’t drag (out) to other models that don’t include a blood oxygen sensor, such as the cheaper Apple Watch SE model.